These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 28870074)

  • 1. Exhaled Volatile Organic Compounds of Infection: A Systematic Review.
    Ahmed WM; Lawal O; Nijsen TM; Goodacre R; Fowler SJ
    ACS Infect Dis; 2017 Oct; 3(10):695-710. PubMed ID: 28870074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid method for breath analysis in cystic fibrosis patients.
    Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
    Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
    Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
    [No Abstract]   [Full Text] [Related]  

  • 5. Breath Biopsy and Discovery of Exclusive Volatile Organic Compounds for Diagnosis of Infectious Diseases.
    Belizário JE; Faintuch J; Malpartida MG
    Front Cell Infect Microbiol; 2020; 10():564194. PubMed ID: 33520731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
    Sun X; Shao K; Wang T
    Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review.
    Moura PC; Raposo M; Vassilenko V
    Biomed J; 2023 Aug; 46(4):100623. PubMed ID: 37336362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients.
    Kos R; Brinkman P; Neerincx AH; Paff T; Gerritsen MG; Lammers A; Kraneveld AD; Heijerman HGM; Janssens HM; Davies JC; Majoor CJ; Weersink EJ; Sterk PJ; Haarman EG; Bos LD; Maitland-van der Zee AH;
    J Cyst Fibros; 2022 Jan; 21(1):e28-e34. PubMed ID: 34016557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
    Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
    Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiological variability in volatile organic compounds (VOCs) in exhaled breath and released from faeces due to nutrition and somatic growth in a standardized caprine animal model.
    Fischer S; Trefz P; Bergmann A; Steffens M; Ziller M; Miekisch W; Schubert JS; Köhler H; Reinhold P
    J Breath Res; 2015 May; 9(2):027108. PubMed ID: 25971714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review.
    Hua Q; Zhu Y; Liu H
    Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro volatile organic compound profiling using GC×GC-TOFMS to differentiate bacteria associated with lung infections: a proof-of-concept study.
    Nizio KD; Perrault KA; Troobnikoff AN; Ueland M; Shoma S; Iredell JR; Middleton PG; Forbes SL
    J Breath Res; 2016 Apr; 10(2):026008. PubMed ID: 27120170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volatile organic compounds (VOCs) fingerprint of Alzheimer's disease.
    Mazzatenta A; Pokorski M; Sartucci F; Domenici L; Di Giulio C
    Respir Physiol Neurobiol; 2015 Apr; 209():81-4. PubMed ID: 25308706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath and urinary volatile organic compounds (VOCs) for cancer diagnoses, and microbial-related VOC metabolic pathway analysis: a systematic review and meta-analysis.
    Zhou M; Wang Q; Lu X; Zhang P; Yang R; Chen Y; Xia J; Chen D
    Int J Surg; 2024 Mar; 110(3):1755-1769. PubMed ID: 38484261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys?
    van Mastrigt E; de Jongste JC; Pijnenburg MW
    Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.